UBE4A

Ubiquitin conjugation factor E4 A · Q14139 · UBE4A on Sugi Atlas →

0 patent compounds predicted against UBE4A, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to UBE4A by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Hypoxia-inducible Factor Prolyl Hydroxylase Inhibitors on Sarcopenia in Hemodialysis Patients PHASE4NOT_YET_RECRUITING
A Trial of Levodopa in Angelman Syndrome PHASE2/PHASE3COMPLETED
Effects of Genistein Aglycone in Glucocorticoid Induced Osteoporosis PHASE2/PHASE3UNKNOWN
Phase II Prospective Cohort Study of Intravesical Recombinant Human Type 5 Adenovirus Injection for Treatment of High-Risk Non-Muscle Invasive Bladder Cancer: Evaluating Efficacy and Safety PHASE2NOT_YET_RECRUITING
Effect of Deferoxamine on Wound Healing Rate in Patients With Diabetes Foot Ulcers PHASE2NOT_YET_RECRUITING
Phase II Study of Vandetanib in Individuals With Kidney Cancer PHASE2COMPLETED
IST Neoadjuvant Abraxane in Newly Diagnosed Breast Cancer PHASE2UNKNOWN
PS-341 and Radiation to Treat Advanced Cancer of the Head and Neck PHASE1COMPLETED
Biomarkers in Tumor Samples From Younger Patients With Neuroblastoma nanCOMPLETED
Differential Gene Expression of Liver Tissue and Blood From Individuals With Chronic Viral Hepatitis nanUNKNOWN
A Natural History Study of Angelman Syndrome nanRECRUITING
Identification of a New Blood Biomarker for the Diagnosis and Prognosis of Liposarcomas nanRECRUITING
Prognostic Value of Combined Approach Based on KEAP1/NFE2L2 Mutations and Pre-therapeutic FDG-PET/CT Radiomic Analysis in Advanced Non-small-cell Lung Cancer PDL1 ≥ 50% Treated With Pembrolizumab (PEMBROMIC) nanUNKNOWN
Clinical Study of 68Ga-DOTA-BLP PET Imaging in Noninvasive Diagnosis of Malignant Tumors nanNOT_YET_RECRUITING
Autophagy in Systemic Lupus Erythematosus nanUNKNOWN
The Role of RING Ubiquitin Ligases in Biologic and Oncologic Processes in Tissues of Mesenchymal Origin nanUNKNOWN
Effect of Adenovirus E1A Oncogene on DNA Replication Dynamics nanUNKNOWN
Exercise Therapy to Reduce Heart Failure Symptoms; Sorting Mechanisms of Benefit nanCOMPLETED
Establishment of a Prospective Clinical-biological Database nanRECRUITING
A Patient-tailored Genetic/Biomarker/iPSC Combined Approach in ALS - PERMEALS nanRECRUITING
Evaluation of Prognostic Factors: From Breast Cancer to Bone Metastases nanUNKNOWN
Establishment of Human Cellular Disease Models for Wilson Disease nanCOMPLETED
Low Dose Melphalan and Bortezomib for AML and High-Risk MDS nanCOMPLETED
The Significance of Urine UbA52 In the Diagnosis of Diabetic Nephropathy nanCOMPLETED
Study of Proteins in Head and Neck Cancer Cells nanCOMPLETED
Transcutaneous Electrical Diaphragmatic Stimulation in Critically Ill Elderly Patients nanUNKNOWN
Using Mobile Technology to Improve Self-Regulation nanCOMPLETED
Inhibition of SENP1 for the Suppression of OS Growth and Metastasis nanUNKNOWN
Diagnostic Potential of UCHL1 in Acute Decompensated Heart Failure nanCOMPLETED
Study of Blood Samples From High-Risk Postmenopausal Women Who Received Treatment on Breast Cancer Prevention Clinical Trials NSABP-P-1 or NSABP-P-2 nanUNKNOWN

Related proteins — ESM-2 sequence neighbours (a UBE4A binder may also engage these)

ProteinNameSimilarity
A5PKG6 1.000 A5PKG6 →
E9Q735 1.000 E9Q735 →
Q5R9G3 1.000 Q5R9G3 →
Q6P7A2 0.997 Q6P7A2 →
Q7KNA0 0.990 Q7KNA0 →
Q7RTS9 0.989 Q7RTS9 →
Q9VX91 0.989 Q9VX91 →
B1AY13 0.989 B1AY13 →
Q6PD03 0.989 Q6PD03 →
Q16K67 0.988 Q16K67 →
Q5ZLW3 0.988 Q5ZLW3 →
USP24 Ubiquitin carboxyl-terminal hydrolase 24 0.988 landscape →
Q6PD19 0.988 Q6PD19 →
Q8IWV7 0.988 Q8IWV7 →
PPP2R5A Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform 0.988 landscape →
NUP205 Nuclear pore complex protein Nup205 0.988 landscape →
A1XD93 0.988 A1XD93 →
Q8BHR2 0.987 Q8BHR2 →
Q8I8U7 0.987 Q8I8U7 →
B4IMI7 0.987 B4IMI7 →
Q8R1F6 0.987 Q8R1F6 →
Q61151 0.987 Q61151 →
XPO5 Exportin-5 0.987 landscape →
Q9V463 0.987 Q9V463 →
Q7SYB2 0.986 Q7SYB2 →
Q5FWU8 0.986 Q5FWU8 →
Q14CX7 0.986 Q14CX7 →
Q9LF41 0.986 Q9LF41 →
G5EGS5 0.986 G5EGS5 →
O94915 0.986 O94915 →